ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INBX Inhibrx Inc

34.06
-0.03 (-0.09%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Inhibrx Inc INBX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.03 -0.09% 34.06 07:59:00
Open Price Low Price High Price Close Price Previous Close
34.16 33.725 34.16 34.06 34.09
more quote information »

Recent News

Date Time Source Heading
12/3/202407:26EDGAR2Form 144 - Report of proposed sale of securities
09/3/202408:08EDGAR2Form 144 - Report of proposed sale of securities
09/3/202407:28EDGAR2Form 144 - Report of proposed sale of securities
07/3/202408:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202406:58EDGAR2Form 144 - Report of proposed sale of securities
05/3/202410:26EDGAR2Form 144 - Report of proposed sale of securities
01/3/202409:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
29/2/202401:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
29/2/202401:12EDGAR2Form 8-K - Current report
29/2/202401:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202408:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202408:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/1/202404:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
24/1/202409:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202422:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202422:35EDGAR2Form 8-K - Current report
23/1/202422:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202421:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202417:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
10/11/202308:03EDGAR2Form 8-K - Current report
10/11/202308:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
03/11/202300:16EDGAR2Form 8-K - Current report
03/11/202300:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
19/10/202307:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
20/9/202306:03EDGAR2Form 8-K - Current report
20/9/202306:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
01/9/202306:06EDGAR2Form D - Notice of Exempt Offering of Securities
29/8/202323:03EDGAR2Form 8-K - Current report
29/8/202323:00PRNUSInhibrx Announces $200 Million Private Placement Financing
08/8/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
30/5/202323:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
30/5/202323:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
09/5/202306:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock